V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20162142 | 20062679 | 1.77 | 87.2 | Palliative (P) | 2016-11-25 | 2016-12-16 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101476596 |
| 20162144 | 20062680 | 1.69 | 53 | Neo-adjuvant (N) | null | 2017-08-21 | ECX | null | null | ECX | 100087585 |
| 20162146 | 20062681 | 1.75 | 75.9 | Neo-adjuvant (N) | 2017-07-01 | 2017-07-02 | ECX | 02 | N | ECX | 101773447 |
| 20162148 | 20062682 | 1.65 | 73.2 | Adjuvant (A) | 2017-04-27 | 2017-05-05 | Gemcitabine + Capecitabine | 2 | N | CAPECITABINE + GEMCITABINE | 101705466 |
| 20162149 | 20062683 | 1.53 | 70.5 | Neo-adjuvant (N) | 2017-07-25 | 2017-07-27 | ECX | N | N | ECX | 101213461 |
| 20162152 | 20062684 | 1.58 | 93.2 | Palliative (P) | 2019-09-09 | 2019-10-03 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101126723 |
| 20162155 | 20062685 | 1.7 | 45.1 | Palliative (P) | 2017-08-21 | 2017-08-28 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100476845 |
| 20162158 | 20062686 | 1.65 | 63.2 | Palliative (P) | 2018-05-27 | 2018-05-27 | ECX | 02 | N | ECX | 100024940 |
| 20162161 | 20062687 | 1.8 | 54.9 | Palliative (P) | 2018-11-29 | 2018-12-01 | ECX | 2 | N | ECX | 101162401 |
| 20162162 | 20062688 | 1.72 | 101.6 | Palliative (P) | 2018-06-18 | 2018-07-02 | ECX | N | N | ECX | 100889770 |
| 20162164 | 20062689 | 1.51 | 63.8 | Adjuvant (A) | 2019-12-20 | 2019-12-30 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101654752 |
| 20162165 | 20062690 | 1.82 | 75.2 | Palliative (P) | 2020-01-11 | 2020-01-12 | Gemcitabine + Capecitabine | N | null | CAPECITABINE + GEMCITABINE | 101295860 |
| 20162166 | 20062691 | 1.68 | 91 | Palliative (P) | 2019-01-26 | 2019-02-03 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100426115 |
| 20162167 | 20062692 | 1.57 | 69 | Neo-adjuvant (N) | 2016-04-09 | 2016-04-24 | ECX | 02 | N | ECX | 101559071 |
| 20162168 | 20062693 | 1.8 | 48.4 | Adjuvant (A) | 2020-02-27 | 2020-03-22 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100231133 |
| 20162173 | 20062694 | 1.82 | 72 | Adjuvant (A) | 2018-02-03 | 2018-02-25 | ECX | N | N | ECX | 100288985 |
| 20162189 | 20062695 | 1.7 | 64 | Neo-adjuvant (N) | 2016-10-15 | 2016-11-05 | ECX | N | N | ECX | 100760703 |
| 20162191 | 20062696 | 1.7 | 68.3 | Neo-adjuvant (N) | 2019-05-12 | 2019-05-19 | ECX | N | Y | ECX | 100096341 |
| 20162200 | 20062697 | 1.7 | 68.25 | Palliative (P) | 2019-08-09 | 2019-08-25 | ECX | N | Y | ECX | 100169652 |
| 20162205 | 20062698 | null | 67.45 | Neo-adjuvant (N) | 2018-05-11 | 2018-05-31 | ECX | N | N | ECX | 100810473 |
| 20162209 | 20062699 | 1.71 | 84 | Curative (C) | 2017-12-18 | 2017-12-29 | ECX | N | N | ECX | 100180336 |
| 20162210 | 20062700 | 1.66 | 64.6 | Palliative (P) | 2016-10-27 | 2016-10-31 | ECX | N | N | CAPECITABINE + GEMCITABINE | 100450920 |
| 20162221 | 20062701 | 1.72 | 82.2 | Palliative (P) | 2019-02-05 | 2019-02-05 | Gemcitabine + Capecitabine | 2 | N | CAPECITABINE + GEMCITABINE | 101174227 |
| 20162225 | 20062702 | 1.55 | 62.2 | Neo-adjuvant (N) | 2016-02-22 | 2016-02-26 | ECX | null | N | ECX | 101295143 |
| 20162226 | 20062703 | 1.69 | 94.1 | Palliative (P) | 2017-10-21 | 2017-11-03 | ECX | 02 | N | ECX | 101674284 |
| 20162229 | 20062704 | 1.69 | 66.1 | Neo-adjuvant (N) | 2017-01-26 | 2017-02-22 | ECX | 02 | N | ECX | 101138151 |
| 20162233 | 20062705 | 1.68 | 62.4 | Adjuvant (A) | 2019-12-30 | 2020-01-20 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101011750 |
| 20162238 | 20062706 | 1.74 | 83.55 | Palliative (P) | 2019-02-23 | 2019-02-24 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100169371 |
| 20162244 | 20062707 | 1.55 | 59.1 | Neo-adjuvant (N) | 2018-05-26 | 2018-06-13 | Gemcitabine + Capecitabine | null | N | CAPECITABINE + GEMCITABINE | 100386317 |
| 20162246 | 20062708 | 1.72 | 54.8 | Neo-adjuvant (N) | 2016-11-14 | 2016-12-11 | ECX | 02 | N | ECX | 101472835 |
| 20162257 | 20062709 | 1.74 | 91.8 | Neo-adjuvant (N) | 2017-10-28 | 2017-11-13 | ECX | N | N | ECX | 101370806 |
| 20162262 | 20062710 | 1.83 | 72 | Palliative (P) | 2016-11-26 | 2016-12-25 | ECX | N | N | ECX | 100467772 |
| 20162266 | 20062711 | 1.54 | 68 | Disease modification (D) | 2018-10-01 | 2018-10-01 | ECX | 02 | N | ECX | 100430600 |
| 20162268 | 20062712 | 1.54 | 61 | Adjuvant (A) | 2019-05-08 | 2019-05-09 | Gemcitabine + Capecitabine | N | Y | CAPECITABINE + GEMCITABINE | 101055127 |
| 20162275 | 20062713 | 1.83 | 58.75 | Palliative (P) | 2016-10-10 | 2016-10-20 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100382787 |
| 20162294 | 20062714 | 1.72 | 61.6 | Palliative (P) | 2019-10-17 | 2019-10-24 | ECX | 02 | N | ECX | 100155285 |
| 20162295 | 20062715 | 1.58 | 49.7 | Neo-adjuvant (N) | 2019-07-21 | 2019-07-21 | ECX | 02 | N | ECX | 100822393 |
| 20162296 | 20062716 | 1.63 | 53.6 | Palliative (P) | 2016-03-02 | 2016-03-13 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100151009 |
| 20162299 | 20062717 | 1.84 | 46.3 | Neo-adjuvant (N) | 2019-04-11 | 2019-04-11 | ECX | 2 | N | ECX | 100360258 |
| 20162307 | 20062718 | 1.85 | 69.4 | Adjuvant (A) | 2019-02-16 | 2019-02-25 | ECX | 02 | N | ECX | 100512039 |
| 20162313 | 20062719 | 1.5 | 117.8 | Palliative (P) | 2017-05-19 | 2017-05-19 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101688110 |
| 20162326 | 20062720 | 1.51 | 67.7 | Curative (C) | 2019-10-12 | 2019-10-18 | ECX | N | N | ECX | 101492483 |
| 20162329 | 20062721 | 0.02 | 78.7 | Palliative (P) | 2017-08-23 | 2017-08-30 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100962641 |
| 20162331 | 20062722 | 1.69 | 126.2 | Neo-adjuvant (N) | 2017-12-15 | 2017-12-27 | ECX | N | N | ECX | 100370490 |
| 20162332 | 20062723 | 1.73 | 70 | Curative (C) | 2019-02-11 | 2019-02-13 | ECX | 02 | null | ECX | 101647876 |
| 20162333 | 20062724 | null | 61.5 | null | 2019-01-23 | 2019-02-13 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101450522 |
| 20162339 | 20062725 | 1.75 | 96 | Palliative (P) | 2018-09-27 | 2018-10-01 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100753634 |
| 20162344 | 20062726 | 1.75 | null | null | null | 2019-08-06 | ECX | null | N | ECX | 100180194 |
| 20162348 | 20062727 | 1.75 | 74 | Adjuvant (A) | null | 2017-04-28 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101257979 |
| 20162352 | 20062728 | 1.73 | 66.6 | Curative (C) | 2019-02-22 | 2019-03-01 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101024994 |